Should You Buy AbbVie Stock After The Recent 7% Fall?

The stock price of AbbVie reached its 52-week high of around $121 just last week before a recent sell-off in ABBV stock, especially after the U.S. FDA stated that all janus kinase inhibitors approved for arthritis treatment should carry a heart-risk warning on the label – sending the stock to lower.

More Stories
12 ‘Old-School’ Marketing Tactics That Still Work